Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DNAJC14 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | LINC01314 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | ITIH6 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | CEACAM21 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | SLC25A43 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | CTB-102L5.4 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
mRNA | RNH1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | PDLIM2 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | RETN | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | TYW5 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |